MS (MC) - Block 1 Flashcards
What are the tx options for acute exacerbations?
Start with corticosteroids
Mild: Oral prednisone or prednisolone
Severe, acute: IV methylprednisolone (Solu-Medrol)
MOA of steroids?
Inhibit leukocyte infiltration at site of inflammation, interfere with mediators of inflammatory responses and suppress humoral immune responses
* Reduce edema in area of demyelination
* Reduce BBB abnormalities and reduce CSF IgG synthesis
What are the adrs for Steroids?
- Cushing’s syndrome (chronic use)
- GI distress
- Impaired skin healing
- Hypertension
- Adrenal insufficiency
- Hyperglycemia, steroid diabetes
What are the cautions of long term steroid use?
Not used for prevention (or disease modifying therapy)
Are disease modifying therapies a cure for MS?
Not a cure still prone to relapse and progressive damage
All are immunomodulating agents
What are ABC therapies?
β-interferons and copaxone (ABCs of MS therapy):
* Home injectable treatments for relapsing-remitting MS (RRMS)
* likely shift from Th1 (pro-inflammatory) to Th2 (anti-inflammatory) cytokine profile
Interferon β-1b
Brand, Structure, MOA, ADR, Monitor, stabilizer
Betaseron, Extavia
Structure: 165 amino acid analog of human Interferon-β
* Cys17 -> Ser
* Also not glycosylated
* Produced in recombinant E.coli
MOA:
* Decreased expression of pro-inflammatory cytokines
* Decreases expression of class II MHC antigens
* Inhibition of helper T-cells
ADR: Inj site rednness and swelling, flu-like sx
* Therapy may cause patients to feel worse initially -> Can apply ice before and after to injection site to decrease redness/pain
* NSAIDs at regular intervals for 24 hrs after administration may help with flu-like symptoms
Moniotr:
* CBC, platelets, LFTs 1,3, 6 months
* THyroid function preiodically
Stabilizer: dextrose and albumin
Interferon β-1a
Brand, Structure, Stabilizers, ADR, Dosing, Monitoring
Avonex, Rebif
Structure: Same amino acid sequence as human IFN-β
Stabilizer: Albumin, sodium chloride and phosphate buffer (do not shake)
ADR: Inj site rednness and swelling, flu-like sx
Dosing:
* Avonex: QW IM
* Rebif: 3W SC
Monitoring: Hb, liver and thyroid function, blood chemistries
Plegridy
MOA
Pegylated interferon β-1a: PEG is attached to interferon -> longer duration SQ 2W
Glatiramer Acetate
Brand, MOA, Indication
Copaxone
MOA: Mix of synthetic polypeptides that modifies immune processes responsible for MS (TH1 to TH2 shift)
* Might also serve as decoy to locally generated auto-antibodies
Indication: Decreases frequency of attacks and severity of disability in RRMS (minimal disabilitiy)
ADR: generally well tolerated, inj site reaction
* Immediate post inj rx: facial flushing, chest pain, dyspnea, throat constriction, palpitations, anxiety (Usually benign and self-limiting)
Glatiramer Acetate Injection
Brand
Glatopa: generic equialent to Copaxone
Describe the number of inj for ABCs?
What is an examples of home injectable therapy?
Ofatumumab (Kesimpta)
Ofatumumab
Brand, MOA
Kesimpta
MOA: Fully human 149 kDa IgG1κ anti-CD20 Mab
* Binds to CD20 on B–cells -> B-cell lysis
ADR: Upper respiratory tract infections, inj-related rx
* Progressive multifocal leukoencephalopathy (PML), Hepatitis B virus (HBV) reactivation
What are the benefits of oral MS tx?
Increased adherence and easier admin
Describe the MOA of Sphingosine 1-phosphate (S1P) receptor modulator?
Causes internalization of receptor:
* Blocks release of lymphocytes from lymph nodes and thymus, reducing number in the blood
* Prevents activated and autoreactive cells from migrating to the CNS
What are the S1P receptor modulators?
- Fingolimod
- Siponimod
- Ozanimod
- Ponesimod
S1P Receptor Modulators
ADR, Metabolism
ADR: HA, high BP, abnormal liver tests, increased infection
Metabolsim: CYP450s
* Siponomod – contraindicated in patients with CYP2C93/3 genotype (may require reduced dosing)
What are cardiac effects of S1P receptor modulators?
Bradycardia, prolongation of QT interval
* Requires cardiac monitoring for 6 hours after first dose
* Contraindicated in patients with cardiac conditions
Terflunomide
MOA, ADR
MOA: Inhibits dihydroorotate dehydrogenase (enzyme in pyrimidine synthesis) -> inhibits T-cell and B-cell division
* Decrease in number of activated lymphocytes in CNS
* active metabolite of leflunomide
ADR: elevation of liver enzymes, reduced WBC, teratogenic
* May be up to 2 years before plasma levels decrease to sufficient amount
Cladribine
MOA, ADR
MOA: Purine nucleoside analog prodrug – activated by deoxycytidine kinase
* Causes failure of DNA damage repair
* High levels of deoxycytidine kinase in T-cells and B-cells
* Reduces levels of pro-inflammatory chemokines
ADR: upper respiratory tract infection, lymphopenia, malignancy
CI: Patients who have reproductive potential with no effective contraception
Dimethyl fumarate
MOA, ADR
MOA: Prodrug converted to monomethyl fumarate
* May activate nuclear factor (erythroid-derived 2)-like 2 (NRF-2) transcriptional pathway that reduces oxidative stress from demylination and anti-inflammatory
ADR: flushing, lymphopenia, N, diarrhea
What is the active fumarate metabolite?
Monomethyl Fumarate
What are the fumarates>
- Dimethyl Fumarate
- Monomethyl Fumarate
- Diroximel Fumarate